Skip to main content
BrainCited

PQQ (Pyrroloquinoline Quinone) 用于 Age-Related Cognitive Decline

C

A double-blind RCT of 64 subjects found 21.5 mg/day PQQ improved memory, attention, and cognitive function after 12 weeks. A separate trial in MCI patients showed cerebral oxygenation increased from 48.4% to 52.8%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dpqq\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
结论

            
            
A double-blind RCT of 64 subjects found 21.5 mg/day PQQ improved memory, attention, and cognitive function after 12 weeks. A separate trial in MCI patients showed cerebral oxygenation increased from 48.4% to 52.8%.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                6 weeks
                
                
                Double-blind
                
            

            
                The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in …
            
            

                
                Dose: None
                
                
                vs: Placebo
                
                
                Outcome: Cognitive function
                
                
                效果: None
                
                
                P = 0.01
                
            

            
            
研究人群: Alzheimer's disease patients

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
4

        
研究数量

    

    

        
200

        
受试者

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
等级

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive …
                        
                        
                            
                                RCT
                            
                            
                            
                        
                    

                    

                        The journal of …
                        2024
                        
                        6 次引用
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
常用剂量

                

                    
                    

                        
general:

                        
10-20 mg/day

                    

                    
                    

                        
cognitivesupport:

                        
20 mg/day

                    

                    
                

                
                

                    上限： Not established; well-tolerated up to 60 mg/day
                

                
            

            

            
            

                
研究中使用的剂量

                

                    

                        
                            

                                剂量
                                持续时间
                                效果
                                N
                            

                        
                        
                            
                            

                                None
                                6 weeks
                                
                                    
                                    Neutral
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                最佳服用时间： With meals
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
已报告的副作用

                    
    
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            Insomnia
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild fatigue
                        
    • 
                        
                    

                

                

                
                

                    
已知相互作用

                    
    
                        
                        
  • 
                            ●
                            No significant drug interactions established
                        
    • 
                        
                    

                

                

                
                

                    

                        可耐受最高摄入量： Not established; well-tolerated up to 60 mg/day
                    

                

                
            

            

                在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does PQQ (Pyrroloquinoline Quinone) help with Age-Related Cognitive Decline?
            
        
        

            Based on 4 studies with 200 participants, there is limited but promising evidence that PQQ (Pyrroloquinoline Quinone) may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much PQQ (Pyrroloquinoline Quinone) should I take for Age-Related Cognitive Decline?
            
        
        

            Studies have used various dosages. A commonly studied range is 10-20 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of PQQ (Pyrroloquinoline Quinone)?
            
        
        

            Reported side effects may include Headache, Insomnia, Mild fatigue. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for PQQ (Pyrroloquinoline Quinone) and Age-Related Cognitive Decline?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
            

        

        

    


    
    












    

        FDA 免责声明:
        这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。